US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.170
  • -0.420-6.37%
Close Oct 1 16:00 ET
  • 6.190
  • +0.020+0.32%
Post 17:04 ET
1.74BMarket Cap-3716P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
13.29M
14.42M
+1.13M
Beat Est.
+20.59%
+30.86%
+8.52%
EPS
-0.38
-0.40
-0.02
Miss Est.
+1.03%
-5.26%
-6.38%
Analyst Rating
Buy

Sep 30, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.671M--
--2024/Q3-- / 30.029M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 14.671M--
--2024/Q3-- / 30.029M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

  • Recursion Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:14 ET

  • Recursion Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:22 ET

  • Recursion Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29 08:33 ET

  • Recursion Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 08:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept NVIDIA Portfolio
    NVIDIA Portfolio
    Intraday-4.82%